Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
| ▸ | ADH4 | P08319 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20816167 | 0.98 | ALDH1A1 (0.32) | ALDH1A1HSD17B10PKM | |
| SCHEMBL20816149 | 0.74 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL27412858 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 | |
| SCHEMBL10882892 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 | |
| SCHEMBL21327703 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 | |
| SCHEMBL8207166 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 | |
| SCHEMBL20816179 | 0.71 | — | — | |
| SCHEMBL10883501 | 0.69 | ALDH1A1 (0.40) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 | |
| SCHEMBL10652990 | 0.69 | — | — | |
| SCHEMBL25249653 | 0.69 | ALDH1A1 (0.41) | ALDH1A1HSD17B10SIGMAR1EPHX1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078569-B2 | Trisilylamine derivatives as precursors for high growth rate silicon-containing films | VERSUM MATERIALS US, LLC (US) | 2021-08-03 | — | — | US | claimed |
| US-20190085452-A1 | Trisilylamine Derivatives as Precursors for High Growth Rate Silicon-Containing Films | VERSUM MATERIALS US, LLC (US) | 2019-03-21 | — | — | US | claimed |
| US-11078569-B2 | Trisilylamine derivatives as precursors for high growth rate silicon-containing films | VERSUM MATERIALS US, LLC (US) | 2021-08-03 | — | — | US | disclosed |
| US-20190085452-A1 | Trisilylamine Derivatives as Precursors for High Growth Rate Silicon-Containing Films | VERSUM MATERIALS US, LLC (US) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190085452-A1 | Trisilylamine Derivatives as Precursors for High Growth Rate Silicon-Containing Films | MSTN, SMS, CCNA2 | ALDH1A1 3626/4885HSD17B10 3883/4885PKM 2728/4885 |
| US-11078569-B2 | Trisilylamine derivatives as precursors for high growth rate silicon-containing films | MSTN, SMS, CCNA2 | ALDH1A1 3626/4885HSD17B10 3883/4885PKM 2728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.